Stimulation of retinoic acid-induced functional sodium iodide symporter (NIS) expression and cytotoxicity of ¹³¹I by carbamazepine in breast cancer cells

By Willhauck Michael   O`Kane Dennis   Wunderlich Nathalie   Göke Burkhard   Spitzweg Christine  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 377-386

Springer Publishing Company

Access to resources Recommend Favorite

The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS)

By Fortunati N.   Catalano M.   Marano F.   Mugoni V.   Pugliese M.   Bosco O.   Mainini F.   Boccuzzi G.  

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 667-675

Springer Publishing Company

Access to resources Recommend Favorite

Effect of sodium/iodide symporter (NIS)-mediated radioiodine therapy on estrogen receptor-negative breast cancer

By              

Oncology Reports, Vol. 34, Iss. 1, 2015-01 ,pp. : 59-66

Spandidos Publications

Access to resources Recommend Favorite

AFP Promoter Enhancer Increased Specific Expression of the Human Sodium Iodide Symporter (hNIS) for Targeted Radioiodine Therapy of Hepatocellular Carcinoma

By Ma Xiao-Juan   Huang Rui   Kuang An-Ren  

Cancer Investigation, Vol. 27, Iss. 6, 2009-07 ,pp. : 673-681

Informa Healthcare

Access to resources Recommend Favorite

Radiofrequency induction on sodium/iodide symporter expression of thyroid cancer

By Tian Youxin   Liu Qinjiang   Ni Yaqiong  

The Chinese-German Journal of Clinical Oncology, Vol. 12, Iss. 11, 2013-11 ,pp. : 516-520

Springer Publishing Company

Access to resources Recommend Favorite